| Quarter | Score |
|---|---|
| 2022-Q3 | 68.0 |
| 2022-Q4 | 50.1 |
| 2023-Q1 | 53.3 |
| 2023-Q2 | 64.9 |
| 2023-Q3 | 48.1 |
| 2023-Q4 | 43.6 |
| 2024-Q1 | 63.8 |
| 2024-Q2 | 41.4 |
| 2024-Q3 | 48.1 |
| 2024-Q4 | 51.4 |
| 2025-Q1 | 47.9 |
| 2025-Q2 | 46.7 |
| 2025-Q3 | 49.7 |
| 2025-Q4 | 47.9 |
| 2026-Q1 | 48.6 |
| 2026-Q2 | 44.5 |
Active institutional exit or low consensus; avoid or liquidate
Trading +20.6% above funds' purchase price — elevated pullback risk
1 of 16 tracked funds hold RBLX. Avg conviction: 3.0%. Net trimming. First tracked at $37.21 (current +20.6% vs tracked).
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 16 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| ValueAct Capital | 3.0% | Reduce |